| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.41▼ | 4.46▼ | 4.49▼ | 4.06▲ | 3.97▲ |
| MA10 | 4.44▼ | 4.54▼ | 4.47▼ | 3.89▲ | 4.14▲ |
| MA20 | 4.44▼ | 4.50▼ | 4.30▲ | 3.89▲ | 4.14▲ |
| MA50 | 4.53▼ | 4.20▲ | 4.00▲ | 4.11▲ | 4.75▼ |
| MA100 | 4.50▼ | 3.98▲ | 3.86▲ | 4.13▲ | 4.20▲ |
| MA200 | 4.36▲ | 3.88▲ | 3.99▲ | 4.59▼ | 3.20▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | -0.037▼ | -0.009▼ | 0.079▲ | 0.019▲ |
| RSI | 33.402▼ | 49.426▼ | 57.335▲ | 65.024▲ | 53.183▲ |
| STOCH | 7.747▼ | 35.352 | 64.878 | 71.969 | 21.611 |
| WILL %R | -100.000▼ | -64.045 | -64.045 | -24.779▲ | -47.368 |
| CCI | -105.310▼ | -90.587 | -60.882 | 223.377▲ | 95.010 |
| CDL | $AQST Engulfing Candlestick Pattern Detected | Set Alert |
|
Tuesday, August 11, 2026 07:00 AM
Successfully completed human factors validation study and pharmacokinetic study for Anaphylm™ (dibutepinephrine) sublingual filmRemains on track to resubmit Anaphylm NDA to the FDA in Q3 2026Continues ...
|
|
Tuesday, August 11, 2026 02:36 AM
Aquestive Therapeutics (NASDAQ:AQST) reports today. Explore the key operating questions around regulatory progress and commercial preparation, business execution, demand quality, and financial ...
|
|
Monday, August 10, 2026 07:24 AM
Aquestive Therapeutics (NASDAQ:AQST) shares rose 9. 5% on Monday after the pharmaceutical company reported positive human factors and pharmacokinetic study results for Anaphylm, strengthening its ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 11/08/26 | 4.26 | 4.69 | 4.24 | 4.41 | 6,386,371 |
| 10/08/26 | 4.35 | 4.635 | 4.26 | 4.29 | 7,179,597 |
| 07/08/26 | 3.95 | 4.035 | 3.865 | 3.94 | 1,848,332 |
| 06/08/26 | 3.76 | 3.92 | 3.76 | 3.92 | 1,525,656 |
| 05/08/26 | 3.74 | 3.8399 | 3.705 | 3.755 | 1,460,869 |
| 04/08/26 | 3.85 | 3.87 | 3.65 | 3.74 | 2,689,406 |
| 03/08/26 | 3.70 | 3.82 | 3.67 | 3.79 | 2,369,100 |
| 31/07/26 | 3.75 | 3.78 | 3.605 | 3.695 | 1,783,778 |
| 30/07/26 | 3.60 | 3.74 | 3.60 | 3.72 | 1,424,873 |
| 29/07/26 | 3.74 | 3.77 | 3.56 | 3.60 | 2,564,062 |
|
|
||||
|
|
||||
|
|